α-Synuclein 种子放大试验 放大参数和发生性帕金森病进展的风险
David G Coughlin1, Ben Shifflett2, Carly M Farris3
1Department of Neurosciences, University of California, San Diego.
Neurology
|February 6, 2025
概括
阿尔法-同核素种子放大试验 (αSyn-SAA) 的阳性和更快的放大表明患帕金森病 (PD) 的风险更高. 这种测试可能有助于预测风险人群的疾病进展.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物发现发现
- 神经退行性疾病 神经退行性疾病
背景情况:
- 在高危人群中对帕金森病 (PD) 的风险评估需要经过验证的工具.
- 阿尔法-同核素种子放大试验 (αSyn-SAA) 是同核素病变的一个有前途的生物标志物.
研究的目的:
- 评估αSyn-SAA的定性结果和放大参数在非表现载体 (NMCs),prodromal PD和PD中.
- 评估αSyn-SAA结果与前进性PD中的转换风险之间的关系.
主要方法:
- 对横截面和纵横脊髓αSyn-SAA的分析来自帕金森病进展标志物倡议的结果.
- 在各组参与者之间比较αSyn-SAA阳性和放大参数 (Fmax,TTT,T50,AUC).
- 基于αSyn-SAA参数的预发性PD中的转换概率的调查.
主要成果:
- 分析了1,027名参与者,159名HC,247名NMC,96名prodromal PD,525名PD.
- 与αSyn-SAA+ NMCs和HCs相比,αSyn-SAA+ prodromal PD和PD中的更快的时间到值 (TTT) 和时间到50%的Fmax (T50),以及更高的曲线下的面积 (AUC).
- 积极的αSyn-SAA和更快的TTT在prodromal PD中与更高的表转化率相关.
结论:
- αSyn-SAA阳性与帕金森病风险增加有关.
- 更快的αSyn-SAA种子放大可能会预测风险人群中的转化.
相关概念视频
Parkinson's Disease: Overview
447
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
447
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K


